Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry Revision: v3.3.3 was added to the record history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe Record History now shows a new revision entry v3.3.2 and removes the previous v3.3.1 entry.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page history now shows Revision: v3.3.1 added and Revision: v3.2.0 removed; no changes to study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedThe government funding notice banner at the top of the page was removed.SummaryDifference0.9%

- Check66 days agoChange DetectedVersion history shows no substantive changes to the study record; the 2023-01-13 entry lists 'Changes: None'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check95 days agoChange DetectedUpgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.SummaryDifference13%

Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.